Skip to main content
Diagnostic Pathology logoLink to Diagnostic Pathology
. 2018 May 2;13:26. doi: 10.1186/s13000-018-0701-4

Retraction Note: The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1

Huifen Li 1, Weihua Huang 2, Rongcheng Luo 2,
PMCID: PMC5932837  PMID: 29720204

Retraction

The editor has retracted this article [1] because it shows significant overlap with the following articles (amongst others) [2, 3]. None of the authors responded to correspondence regarding this retraction.

Footnotes

The original article can be found online at 10.1186/s13000-015-0323-z

References

  • 1.Li H, Huang W, Luo R. The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1. Diagn Pathol. 2015;10:117. doi: 10.1186/s13000-015-0323-z. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 2.Yao S, Zhao T, Jin H. Expression of MicroRNA-325-3p and its potential functions by targeting HMGB1 in non-small cell lung cancer. Biomed Pharmacother. 2015;70:72–79. doi: 10.1016/j.biopha.2015.01.013. [DOI] [PubMed] [Google Scholar]
  • 3.Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, Tang ZY, Wang XW. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology. 2008;47(3):897–907. doi: 10.1002/hep.22160. [DOI] [PubMed] [Google Scholar]

Articles from Diagnostic Pathology are provided here courtesy of BMC

RESOURCES